Portal-systemic encephalopathy, which occurs as a consequence of cirrhosis of the liver, is associated with a variety of neuropsychiatric symptoms. Problems related to the differential diagnosis and medical management of portal-systemic encephalopathy, as compared to other more usual psychiatric disorders, are discussed. Also addressed are issues of particular concern to psychiatry, such as the use of pharmacotherapeutics and the rehabilitation of alcoholism, which are commonly seen in individuals with portal-systemic encephalopathy and liver disease, as well as in the general psychiatric patient population.
Get full access to this article
View all access options for this article.
References
1.
AnsleyJ.IsaacsJ.RikkersL.KutnerM.NordbingerB., and RudmanD., Quantitative Tests of Nitrogen Metabolism in Cirrhosis: Relation to Other Manifestations of Liver Disease, Gastroenterology, 75, pp. 570–579, 1978.
2.
PlumF., The CSF in Hepatic Encephalopathy, Experimental Biology and Medicine, 39, pp. 1246–1258, 1971.
3.
DuffyT. and PlumF., Hepatic Encephalopathy, in The Liver: Biology and Pathobiology, AriasJ.PopperH.SchacterD., and ShafritzD. (eds.), Raven Press, New York, pp. 693–715, 1982.
4.
PosnerJ. and PlumF., The Toxic Effects of Carbon Dioxide and Acetazodamide in Hepatic Encephalopathy, Journal of Clinical Investigation, 39, pp. 1246–1258, 1960.
5.
JamesJ.MacDonaldL., and XanalatosC., Effect of Ammonium Salts on Brain Metabolism, Journal of Neurology, Neurosurgery and Psychiatry, 37, pp. 498–593, 1974.
6.
GalambosJ., Cirrhosis: Epidemiology, in Major Problems in Internal Medicine, SmithL. (ed.), W. B. Saunders, Philadelphia, pp. 91–127, 1979.
7.
LieberC. and LeoM., Alcohol and the Liver, in Medical Disorders of Alcoholism: Pathogenesis and Treatment, LieberC. (ed.), W. B. Saunders, Philadelphia, pp. 259–312, 1982.
8.
VictorM., Neurologic Disorders Due to Alcoholism and Malnutrition, Clinical Neurology, BakerA. and BakerL. (eds.), Harper and Row, Hagerstown, MD, 1979.
9.
ReadA.SherlockS.LaidlawJ., and WalkerJ., The Neuropsychiatric Syndromes Associated with Chronic Liver Disease and an Extensive Portal-Systemic Collateral Circulation, Quarterly Journal of Medicine, 36, pp. 135–150, 1967.
10.
SherlockS.SummerskillW.WhiteL., and PheurE., Portal-Systemic Encephalopathy, Neurological Complication of Liver Disease, Lancet, 2, pp. 453–457, 1954.
11.
SummerskillW.DavidsonE.SherlockS., and SternerR., The Neuropsychiatric Syndrome Associated with Hepatic Cirrhosis and an Extensive Portal Collateral Circulation, Quarterly Journal of Medicine, 25, pp. 245–266, 1956.
12.
HavensL. and ChildC., Recurrent Psychosis Associated with Liver Disease and Elevated Blood Ammonia, New England Journal of Medicine, 252, pp. 756–759, 1955.
13.
LeevyC., Exploring the Brain-Liver Relationship, Modern Medicine, 42, pp. 17–22, 1974.
14.
DickesR.SchenkerV., and DeutschL., Serial Liver Function and Blood Studies in Patients Receiving Chlorpromazine, New England Journal of Medicine, 256, pp. 1–7, 1957.
15.
GundersenH. and AmidsenA., The Electrophoretic Pattern of Alkaline Phosphatase in Schizophrenic Females under Long-Term Treatment with Neuroleptic Drugs and in Young and Old Healthy Women, Scandinavian Journal of Clinical and Laboratory Investigation, 24, pp. 173–177, 1969.
16.
LaidlawJ.ReadA., and SherlockS., Morphine Tolerance in Hepatic Cirrhosis, Gastroenterology, 40, pp. 389–396, 1961.
17.
ReadA.LaidlawJ., and McCarthyC., Effect of Chlorpromazine in Patients with Hepatic Disease, British Medical Journal, 3, pp. 497–499, 1969.
18.
MorganM. and ReadA., Antidepressants and Liver Disease, Gut, 13, pp. 697–701, 1972.
19.
AlvinJ.McHorseT., and HoyumpaA., The Effect of Liver Disease in Man on the Disposition of Phenobarbital, Journal of Pharmacology and Experimental Therapeutics, 192, pp. 224–235, 1975.
20.
SchenkerS.HoyumpaA., and WilkinsonG., The Effect of Parenchymal Liver Disease on the Disposition and Elimination of Sedatives and Analgesics, Medical Clinics of North America, 59, pp. 887–896, 1975.
21.
HoyumpaA.BranchR., and SchenkerS., The Disposition and Effects of Sedatives and Analgesics in Liver Disease, Annual Review of Medicine, 29, pp. 205–218, 1978.
22.
KlotzM.ArantG., and HoyumpaA., The Effects of Age and Liver Disease on the Disposition and Elimination of Diazepan in Adult Men, Journal of Clinical Investigation, 55, pp. 347–359, 1975.
23.
KrausJ.DesmondP.MarshallJ.JohnsonB.SchenkerS., and WilkinsonR., Effects of Aging and Liver Disease on Disposition of Iovazepam, Clinical Pharmacology and Therapeutics, 24, pp. 411–419, 1978.
24.
RobertsR.WilkinsonC., and BranchR., Effect of Age and Cirrhosis on the Disposition and Elimination of Chlordiazepoxide (librium), Gastroenterology, 73, pp. 1243–1245, 1977.
25.
ShullH.WilkinsonG.JohnsonR., and SchenkerS., Normal Disposition of Oxazepan in Acute Viral Hepatitis and Cirrhosis, Annals of Internal Medicine, 84, pp. 420–425, 1976.
26.
McClainC., When Liver Disease Causes Brain Damage, Geriatrics, 198, pp. 74–89, 1980.
27.
RehnstromS.SimertG.HanssonJ.JohnsonG., and VangJ., Chronic Hepatic Encephalopathy: A Psychometrical Study, Scandinavian Journal of Gastroenterology, 12, pp. 305–311, 1977.
28.
ConnH.LeevyC.VahcevicZ.RodgersJ.MaddreyW.SeeffL., and LevyL., Comparison of Lactulose and Neomycin in the Treatment of Chronic Portal-Systemic Encephalopathy: A Double Blind Controlled Trial, Gastroenterology, 72, pp. 573–583, 1977.
29.
GilberstadtS.GilberstadtH.ZieveL.BuegelB.CollierR., and McClainC., Psychomotor Performance Deficits in Cirrhotic Patients without Overt Encephalopathy, Annals of Internal Medicine, 140, pp. 519–521, 1980.
30.
ElithornA.LanzerM., and WeinmanJ., Cognitive Deficits Associated with Chronic Hepatic Encephalopathy and Their Response to Levodopa, Journal of Neurology, Neurosurgery and Psychiatry, 38, pp. 794–798, 1975.
31.
ElsassP.LundY., and RanekL., Encephalopathy in Patients with Cirrhosis of the Liver, A Neuropsychological Study, Scandinavian Journal of Gastroenterology, 13, pp. 241–247, 1978.
32.
RikkersL.JenkoP.RudmanD., and FriedesD., Subclinical Hepatic Encephalopathy: Detection, Prevalence and Relationship to Nitrogen Metabolism, Gastroenterology, 75, pp. 462–469, 1978.
33.
TarterR.HegedusA.Van ThielD.SchadeR.GavalerJ., and StarzlT., Nonalcoholic Cirrhosis Associated with Neuropsychological Dysfunction in the Absence of Overt Evidence of Hepatic Encephalopathy, Gastroenterology, 86, pp. 1421–1427, 1984.
34.
ResnickR.IshiharaA.ChalmersT., and SchimmelE., The Boston Inter-Hospital Liver Group: A Controlled Trial of Colon Bypass in Chronic Hepatic Encephalopathy, Gastroenterology, 54, pp. 1057–1069, 1968.
35.
SimmonsF.GoldsteinH., and BoyleJ., A Controlled Clinical Trial of Lactulose in Hepatic Encephalopathy, Gastroenterology, 59, pp. 827–832, 1970.
36.
AtkinsonM. and GoligherJ., Recurrent Hepatic Coma Treated by Colectomy and Heorectal Anastomosis, Lancet, 1, pp. 461–464, 1960.
37.
GermainL.FrexinosJ.LouisA., and RibetA., Effect of Lactulose on Postshunt Hepatic Encephalopathy: A Controlled Trial, Archives Francaises des Maladies de l'Appareil Digestif, 62, pp. 293–301, 1973.
38.
BreenK. and SchenkerS., Hepatic Coma: Present Concepts of Pathogenesis and Therapy, in Progress in Liver Disease, PopperH. and SchaffnerF. (eds.), Grune and Stratton, pp. 301–322, 1972.
39.
Parsons-SmithB.SummerskillW.DawsonA., and SherlockS., The Electroencephalogram in Liver Disease, Lancet, 2, pp. 867–871, 1957.
40.
ConnH. and LieberthalM., The Hepatic Coma Syndrome and Lactulose, Williams and Wilkins, Baltimore, pp. 1–419, 1978.
41.
AustenF.CarmichaelM., and AdamsR., Neurologic Manifestations of Chronic Pulmonary Insufficiency, New England Journal of Medicine, 25, pp. 579–590, 1957.
42.
HimerichH.HadidamZ.FrazekasJ., and HoaglandH., Cerebral Metabolism and Electrical Activity during Insulin Hypoglycemia in Man, American Journal of Physiology, 125, pp. 578–585, 1939.
43.
EngelG. and RomanoJ., Delerium: A Syndrome of Cerebral Insufficiency, Journal of Chronic Disease, 9, pp. 260–277, 1959.
44.
EngelG. and RomanoJ., Delerium II. Reversibility of Electroencephalogram with Experimental Procedures, Archives of Neurology and Psychiatry, 51, pp. 378–392, 1944.
45.
FoleyJ.WatsonC., and AdamsR., Significance of Encephalographic Changes in Hepatic Coma, Transactions of the American Neurological Association, 75, pp. 161–165, 1950.
46.
DudrickS.MacKieJ., and SerlinO., Surgical Exclusion of the Colon for Chronic Hepatic Encephalopathy, American Journal of Surgery, 115, pp. 57–62, 1968.
47.
GeffroyY.SegrestinM., and GeffroyP., Inteact du Lactulose dans la Traitement de l'Encephalopathic Portocave Chronique—A Propos de 20 Observations, Therapeutique, 46, pp. 897–901, 1970.
48.
FungW. and KooO., Lactulose in the Treatment of Acute and Chronic Hepatic Encephalopathy, Singapore Medical Journal, 12, pp. 175–180, 1971.
49.
ReynoldsT.RedekerA., and DavisP., A Controlled Study of the Effects of L-arginine on Hepatic Encephalopathy, American Journal of Medicine, 25, pp. 359–367, 1958.
50.
NorenbergM., A Light and Electron Microscopic Study of Experimental Portal-Systemic Encephalopathy, Progression and Reversal of the Disorder, Laboratory Investigation, 36, pp. 618–627, 1977.
51.
TarterR.Van ThielD.HegedusA.SchadeR.GavalerJ., and StarzlT., Neuropsychiatric Status Following Liver Transplantation, Journal of Laboratory and Clinical Medicine, 103, pp. 776–782, 1984.
52.
AdamsR. and FoleyJ., The Neurological Changes in the More Common Types of Severe Liver Disease, Transactions of the American Neurological Association, 74, pp. 217–219, 1975.
53.
CourvilleC., Effects of Alcohol on the Central Nervous System, San Lucas Press, Los Angeles, 1955.
54.
RileyJ. and WalkerD., Morphological Alterations in Hippocampus after Long-Term Alcohol Consumption in Mice, Science, 201, pp. 646–648, 1978.
55.
SmithJ. and SmithL., WAIS Functioning of Cirrhotic and Noncirrhotic Alcoholics, Journal of Clinical Psychology, 33, pp. 309–313, 1977.
56.
TarterR.HegedusA.Van ThielD.SchadeR.IwatsukiS., and StarzlT., Neuropsychological Capacity of Alcoholic and Non-Alcoholic Cirrhotics, Alcoholism: Clinical and Experimental Research, 7, p. 123, 1983.
57.
AckerW.MajumdarS.ShawG., and ThomsonA., The Relationship between Brain and Liver Damage in Chronic Alcoholic Patients, Journal of Neurology, Neurosurgery and Psychiatry, 45, pp. 984–987, 1982.
58.
JohannessonG.BerglundM., and IngvarD. H., Reduction of Blood Flow in Cerebral White Matter in Alcoholics Related to Hepatic Function: A CBF and EEG Study, Acta Neurologica Scandinavica, 65, pp. 190–202, 1982.
59.
KardelT. and StigsbyB., Period Amplitude Analysis of the Electroencephalogram Correlated with Liver Function in Patients with Cirrhosis of the Liver, Electroencephalography and Clinical Neurophysiology, 38, pp. 605–609, 1975.
60.
KardelT.OlsenZander P.StigsbyB., and TonnesenK., Hepatic Encephalopathy Evaluated by Automatic Period Analysis of the Electroencephalogram during Lactulose Treatment, Acta Medica Scandinavica, 192, pp. 493–498, 1972.
61.
TarterR.HegedusA.Van ThielD.SchadeR.Pollit-HeylA., and GavalerJ., Association between Hepatic Dysfunction and Neuropsychological Capacity in Cirrhotic Alcoholics, Alcoholism: Clinical and Experimental Research, 8, p. 123, 1984.
62.
O'LearyM.DonovanD.ChaneyE., and WalkerR., Cognitive Impairment and Treatment Outcome with Alcoholics: Preliminary Findings, Journal of Clinical Psychology, 40, pp. 397–398, 1979.
63.
BerglundM.LeijonquistH., and HorlenM., Prognostic Significance and Reversibility of Cerebral Dysfunction in Alcoholics, Journal of Studies on Alcohol, 38, pp. 1761–1769, 1977.
64.
GregsonR. and TaylorG., Prediction of Relapse in Men and Alcoholics, Journal of Studies on Alcohol, 38, pp. 1749–1759, 1977.
65.
HeatonR.CheluneG., and LehmanR., Using Neuropsychological and Personality Tests to Assess the Likelihood of Patient Employment, Journal of Nervous and Mental Disease, 166, pp. 408–416, 1978.
66.
HeatonR. and PendletonM., Using Neuropsychological Tests to Predict Adult Patient's Everyday Functioning, Journal of Consulting and Clinical Psychology, 49, pp. 807–821, 1981.
